FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Simulation software aids drug discovery

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

Accelrys has unveiled version 2.5 of its Discovery Studio modeling and simulation software, which runs on the Pipeline Pilot operating platform.

Software enhancements include updated small molecule modeling, fragment-based design, trans-membrane protein analysis and antibody modeling. So-called discovery guides allow users to combine scientific algorithms and functionality to create a personalized task flow, according to an announcement.

In addition, the company says it has improved Pipeline Pilot integration, allowing users to access scientific components and protocols to extend scientific methods. Such methods can then be deployed within a group via Web Port or Microsoft Sharepoint for collaboration. The software also provides access to the GOLD docking program, licensed by CCDC, allowing GOLD users to benefit from the robust features of Discovery Studio for model preparation and docking analysis.

The Discovery Studio architecture also provides access to products developed by partners in the Accelrys ISV ecosystem, allowing integration of third-party algorithms.

- here's the announcement


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about drug discovery   simulation   small molecule